Related Experiment Videos

[Clinical experiences with femovan (Gynera)]

K Brill1, B Düsterberg, M Albring

  • 1Pharma Deutschland Medizin, Schering Aktiengesellschaft, Berlin.

Summary

This study confirms the high contraceptive effectiveness and excellent menstrual cycle control of the low-dose oral contraceptive Femovan/Gynera. The combined Ethinylestradiol and Gestoden formulation demonstrated a low incidence of unwanted side-effects in over 100,000 women.

Related Concept Videos